• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Myelofibrosis

Direct and communicative, Dr. Christopher Yasenchak approaches situations and conversations in a forthright manner. He believes in stating the facts and then providing all the options in clear and understandable ways. He takes a team approach to working with patients, ensuring every patient develops with him a personalized treatment plan through a shared decision-making process.

“I enjoy seeing patients live better, longer lives as a result of the work we do together,” he says.

As a co-investigator for numerous clinical trials on novel treatments for hematologic malignancies, and associate chair for the Hematology Research Program of US Oncology Research, Dr. Yasenchak avidly works to provide patients access to state-of-the-art clinical trials close to home.